Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's ...
Hims & Hers (NYSE:HIMS) stock tumbled 20% in post-market trading Monday after the company released its Q4 earnings report and ...
Health-care companies rose as traders rotated into defensive sectors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback